NYSE:SNY - Sanofi News Headlines

Sign in or create an account to add this stock to your watchlist.
$41.33 -0.82 (-1.95 %)
(As of 02/21/2019 04:00 PM ET)
Previous Close$42.15
Today's Range$41.26 - $41.67
52-Week Range$37.43 - $45.62
Volume1.33 million shs
Average Volume911,245 shs
Market Capitalization$103.66 billion
P/E Ratio13.20
Dividend Yield2.85%
Beta0.67

Headlines

Sanofi (NYSE SNY) News Headlines

Source:
DateHeadline
America’s Unsafe Medical ProductsAmerica’s Unsafe Medical Products
247wallst.com - February 19 at 6:52 PM
Zacks: Analysts Expect Sanofi SA (SNY) Will Announce Earnings of $0.76 Per ShareZacks: Analysts Expect Sanofi SA (SNY) Will Announce Earnings of $0.76 Per Share
www.americanbankingnews.com - February 17 at 7:10 PM
Sanofi SA (SNY) Receives Consensus Recommendation of "Hold" from AnalystsSanofi SA (SNY) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 17 at 1:30 AM
Novo Nordisk, Sanofi must face lawsuit over insulin pricing: judge - ReutersNovo Nordisk, Sanofi must face lawsuit over insulin pricing: judge - Reuters
www.reuters.com - February 15 at 6:25 PM
SNY Makes Notable Cross Below Critical Moving AverageSNY Makes Notable Cross Below Critical Moving Average
www.nasdaq.com - February 15 at 8:36 AM
A 60% Price Cut Shows Heat Is Still on Drug CompaniesA 60% Price Cut Shows Heat Is Still on Drug Companies
www.barrons.com - February 12 at 8:33 AM
Sanofi/Regeneron Cut Price of PCSK9 Inhibitor Praluent by 60%Sanofi/Regeneron Cut Price of PCSK9 Inhibitor Praluent by 60%
www.zacks.com - February 12 at 8:33 AM
Sanofi and Regeneron cut list price of cholesterol drug by 60 percent - ReutersSanofi and Regeneron cut list price of cholesterol drug by 60 percent - Reuters
www.reuters.com - February 11 at 6:32 PM
Regeneron, Sanofi to offer new Praluent high cholesterol drug options at 60% discountRegeneron, Sanofi to offer new Praluent high cholesterol drug options at 60% discount
www.marketwatch.com - February 11 at 9:14 AM
Sanofi and Regeneron cut list price of cholesterol drug by 60 percentSanofi and Regeneron cut list price of cholesterol drug by 60 percent
finance.yahoo.com - February 11 at 9:14 AM
Sanofi and Regeneron offer Praluent® (alirocumab) at a new reduced U.S. list priceSanofi and Regeneron offer Praluent® (alirocumab) at a new reduced U.S. list price
finance.yahoo.com - February 11 at 9:14 AM
Sanofi and Regeneron cut list price of cholesterol drug by 60 pctSanofi and Regeneron cut list price of cholesterol drug by 60 pct
finance.yahoo.com - February 11 at 9:14 AM
Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several DrugsPharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs
www.zacks.com - February 8 at 8:30 AM
Alnylam's (ALNY) Q4 Earnings and Revenues Beat EstimatesAlnylam's (ALNY) Q4 Earnings and Revenues Beat Estimates
finance.yahoo.com - February 8 at 8:30 AM
Sanofi (SNY) Earning Favorable Press Coverage, InfoTrie ReportsSanofi (SNY) Earning Favorable Press Coverage, InfoTrie Reports
www.americanbankingnews.com - February 8 at 5:29 AM
Sanofi (SNY) Posts  Earnings Results, Beats Estimates By $0.01 EPSSanofi (SNY) Posts Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - February 7 at 10:52 AM
Sanofi (SNY) Updates FY 2019 Earnings GuidanceSanofi (SNY) Updates FY 2019 Earnings Guidance
www.americanbankingnews.com - February 7 at 10:34 AM
Sanofi Q4 Profit Doubles; Sees Growth In FY19 Business EPSSanofi Q4 Profit Doubles; Sees Growth In FY19 Business EPS
www.nasdaq.com - February 7 at 8:33 AM
Sanofi: 4Q Earnings SnapshotSanofi: 4Q Earnings Snapshot
finance.yahoo.com - February 7 at 8:33 AM
Sanofi guides +5% net income for 2019Sanofi guides +5% net income for 2019
seekingalpha.com - February 7 at 8:33 AM
Sanofi Q4 Profit Surges, Sees Earnings Growth In FY19Sanofi Q4 Profit Surges, Sees Earnings Growth In FY19
www.nasdaq.com - February 7 at 8:33 AM
Sanofi Q4 top line up 4%Sanofi Q4 top line up 4%
seekingalpha.com - February 7 at 8:33 AM
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales GrowthSanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth
www.zacks.com - February 7 at 8:33 AM
Can Sanofi (SNY) Keep the Earnings Surprise Streak Alive?Can Sanofi (SNY) Keep the Earnings Surprise Streak Alive?
finance.yahoo.com - February 5 at 6:19 PM
Sanofis isatuximab successful in late-stage multiple myeloma studySanofi's isatuximab successful in late-stage multiple myeloma study
seekingalpha.com - February 5 at 8:46 AM
How Does Sanofi (EPA:SAN) Fare As A Dividend Stock?How Does Sanofi (EPA:SAN) Fare As A Dividend Stock?
finance.yahoo.com - February 4 at 8:49 AM
Sanofi (SNY) to Release Earnings on ThursdaySanofi (SNY) to Release Earnings on Thursday
www.americanbankingnews.com - January 31 at 1:50 AM
Undeterred by Sanofis stumble, Takeda takes similar path with dengue shotUndeterred by Sanofi's stumble, Takeda takes similar path with dengue shot
finance.yahoo.com - January 30 at 8:27 AM
Sanofi says were as ready as can be for BrexitSanofi says we're 'as ready as can be' for Brexit
finance.yahoo.com - January 30 at 8:27 AM
Takeda dengue vaccine meets main goal of trial; detailed results to comeTakeda dengue vaccine meets main goal of trial; detailed results to come
finance.yahoo.com - January 29 at 8:28 AM
[$$] Takedas Dengue Vaccine Works Safely, Company Says[$$] Takeda's Dengue Vaccine Works Safely, Company Says
finance.yahoo.com - January 29 at 8:28 AM
14 Safer Dividend Survivors In Buffett/Kiplinger/Gates 80 Trifecta Picks For 201914 'Safer Dividend Survivors In Buffett/Kiplinger/Gates 80 Trifecta Picks For 2019
seekingalpha.com - January 25 at 6:02 PM
Advisory Panel Votes In Split Fashion For Lexicons Drug: What Does That Mean For Approval?Advisory Panel Votes In Split Fashion For Lexicon's Drug: What Does That Mean For Approval?
seekingalpha.com - January 22 at 6:14 PM
Alnylam & Medison Partner to Market RNAi Products in IsraelAlnylam & Medison Partner to Market RNAi Products in Israel
finance.yahoo.com - January 22 at 8:32 AM
Corporate Europe Faces ‘Unbearable’ Brexit Uncertainty - The Wall Street JournalCorporate Europe Faces ‘Unbearable’ Brexit Uncertainty - The Wall Street Journal
www.wsj.com - January 18 at 9:00 AM
Regeneron (REGN) Sails Steady on Label Expansion of DrugsRegeneron (REGN) Sails Steady on Label Expansion of Drugs
finance.yahoo.com - January 16 at 5:47 PM
[$$] Sanofi and Novo Nordisk press ahead with US insulin prices rises[$$] Sanofi and Novo Nordisk press ahead with US insulin prices rises
finance.yahoo.com - January 10 at 8:46 AM
Emergent (EBS) Up on '19 View, Posts Preliminary '18 ResultsEmergent (EBS) Up on '19 View, Posts Preliminary '18 Results
finance.yahoo.com - January 9 at 8:41 AM
U.S. top court rejects Amgen over cholesterol medication patent fight - ReutersU.S. top court rejects Amgen over cholesterol medication patent fight - Reuters
www.reuters.com - January 8 at 8:35 AM
Regeneron to receive $462M from Sanofi in revamped I-O collaborationRegeneron to receive $462M from Sanofi in revamped I-O collaboration
seekingalpha.com - January 7 at 8:25 AM
Drugmakers Sanofi, Regeneron restructure immuno-oncology dealDrugmakers Sanofi, Regeneron restructure immuno-oncology deal
finance.yahoo.com - January 7 at 8:25 AM
Sanofi to pay Regeneron $580 million in revised immuno-oncology dealSanofi to pay Regeneron $580 million in revised immuno-oncology deal
finance.yahoo.com - January 7 at 8:25 AM
Sanofi to pay Regeneron $580 mln in revised immuno-oncology dealSanofi to pay Regeneron $580 mln in revised immuno-oncology deal
finance.yahoo.com - January 7 at 8:25 AM
Factbox - Bristol-Myers $74 billion Celgene buy has investors looking for next deal - Yahoo! Finance NewsFactbox - Bristol-Myers' $74 billion Celgene buy has investors looking for next deal - Yahoo! Finance News
finance.yahoo.com - January 4 at 8:59 AM
SNY Named Top 10 SAFE International Dividend StockSNY Named Top 10 SAFE International Dividend Stock
www.nasdaq.com - January 2 at 8:32 AM
Opiant Licenses Novel CB-1 Receptor Antagonist For Treatment Of ACO From SanofiOpiant Licenses Novel CB-1 Receptor Antagonist For Treatment Of ACO From Sanofi
www.nasdaq.com - December 26 at 8:35 AM
Opiant Pharmaceuticals licenses drinabant from Sanofi for treatment of ACOOpiant Pharmaceuticals licenses drinabant from Sanofi for treatment of ACO
seekingalpha.com - December 26 at 8:35 AM
Sanofi-Aventis Reports EU Approval Of Dengue Vaccine - Quick FactsSanofi-Aventis Reports EU Approval Of Dengue Vaccine - Quick Facts
www.nasdaq.com - December 19 at 8:33 AM
Sanofi to move listing from NYSE to NasdaqSanofi to move listing from NYSE to Nasdaq
www.marketwatch.com - December 19 at 8:33 AM
5 Top Drug/Biotech Merger & Acquisition Targets for 20195 Top Drug/Biotech Merger & Acquisition Targets for 2019
www.zacks.com - December 10 at 8:24 AM
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel